89bio's market cap is currently ―. The company's EPS TTM is $-2.013; its P/E ratio is -4.51; 89bio is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -33.77M	$ -37.50M	$ -26.76M	$ -24.83M	$ -27.04M
EBITDA	$ -35.68M	$ -38.46M	$ -27.61M	$ -25.03M	$ -27.02M
Net Income Common Stockholders	$ -34.73M	$ -38.39M	$ -28.84M	$ -24.60M	$ -26.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 251.93M	$ 245.44M	$ 350.93M	$ 55.26M	$ 193.34M
Total Assets	$ 460.11M	$ 492.51M	$ 494.24M	$ 196.82M	$ 200.58M
Total Debt	$ 24.87M	$ 24.75M	$ 24.64M	$ 20.05M	$ 20.02M
Net Debt	$ -227.06M	$ -220.69M	$ -326.29M	$ -35.21M	$ -173.32M
Total Liabilities	$ 49.90M	$ 50.52M	$ 48.49M	$ 44.99M	$ 48.01M
Stockholders Equity	$ 410.21M	$ 441.99M	$ 445.83M	$ 151.83M	$ 152.57M
Cash Flow	-
Free Cash Flow	$ -30.36M	$ -34.45M	$ -30.09M	-	$ -14.81M
Operating Cash Flow	$ -30.36M	$ -34.45M	$ -30.09M	-	$ -14.81M
Investing Cash Flow	$ 38.33M	$ -101.81M	$ 4.11M	-	$ -42.06M
Financing Cash Flow	$ -1.48M	$ 30.77M	$ 321.65M	-	$ 68.63M

Currency in USD

89bio Earnings and Revenue History

Income Statement >

89bio Debt to Assets

Balance Sheet >

89bio Cash Flow

Cash Flow >

89bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing